Patent ID: 9233094
Filing Date: 2016-01-12
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating pancreatic cancer comprising administering to a human subject in need thereof a cationic liposomal formulation comprising at least one cationic lipid in an amount from about 30 mole % to about 99.9 mole %, paclitaxel in an amount of at least about 0.1 mole %, and a neutral lipid in an amount from about 30 mole % to about 70 mole %, wherein the cationic liposomaal formulation has a positive zeta potential in about 0.05 M KCI solution at about pH 7.5 at room temperature, and wherein the liposomal formulation is administered twice a week, wherein a single dose of paclitaxel is about 0.05 mg/kg body weight (bw) to about 1.25 mg/kg bw of the patient.